Inventor · disambiguated record
David Wraith
Also filed as: WRAITH DAVID · WRAITH DAVID CAMERON
14 granted patents·14 pending applications·114 citations·filing 2001–2023
89Inventor score
Files withAPITOPE INT NV10APITOPE TECH BRISTOL LIMITED5APITOPE TECHNOLOGY BRISTOL LTD5WRAITH DAVID3APITOPE TECH (BRISTOL) LTD1
Top patents by PatentIndex Score
28 records- 0195US8343500B2Peptide compositionAPITOPE TECHNOLOGY BRISTOL LTD·Filed 2007·Granted Jan 1, 2013·97 cites·1 claims
- 0280US10730919B2PeptidesAPITOPE INT NV·Filed 2018·Granted Aug 4, 2020·1 cites·21 claims
- 0379US9938329B2PeptidesAPITOPE INT NV·Filed 2014·Granted Apr 10, 2018·4 cites·11 claims
- 0479US8623827B2Myelin basic protein peptide compositionWRAITH DAVID·Filed 2008·Granted Jan 7, 2014·4 cites·3 claims
- 0574US2024148843A1PeptideAPITOPE TECH BRISTOL LIMITED·Filed 2023·Application pending·0 cites
- 0673US8445448B2FVIII peptides and their use in tolerising haemophiliacsWRAITH DAVID·Filed 2008·Granted May 21, 2013·2 cites·8 claims
- 0772US10646589B2Thyroid stimulating hormone receptor peptides and uses thereofAPITOPE INT NV·Filed 2015·Granted May 12, 2020·2 cites·12 claims
- 0869US9862751B2Myelin oligodendrocyte glycoprotein peptidesAPITOPE INT NV·Filed 2014·Granted Jan 9, 2018·1 cites·4 claims
- 0964US2024165264A1T cell activationUNIV BIRMINGHAM·Filed 2023·Application pending·0 cites
- 1063US2022016226A1PeptideAPITOPE TECH BRISTOL LIMITED·Filed 2021·Application pending·0 cites
- 1161US2021346476A1Modified FVIII Apitope PeptidesAPITOPE INT NV·Filed 2021·Application pending·0 cites
- 1259US9381234B2Methods of using myelin basic protein peptide compositionsAPITOPE TECHNOLOGY BRISTOL LTD·Filed 2013·Granted Jul 5, 2016·0 cites·12 claims
- 1358US8961986B2Peptide compositionAPITOPE TECHNOLOGY BRISTOL LTD·Filed 2012·Granted Feb 24, 2015·0 cites·10 claims
- 1458US7071297B2Tolerogenic peptides from myelin basic proteinAPITOPE TECHNOLOGY BRISTOL LTD·Filed 2004·Granted Jul 4, 2006·3 cites·16 claims
- 1558US2015352197A1PeptideAPITOPE INT NV·Filed 2014·Application pending·0 cites
- 1654US2019275126A1PeptideAPITOPE TECH BRISTOL LIMITED·Filed 2019·Application pending·0 cites
- 1749US9775880B2Methods of using myelin basis protein peptide compositionsAPITOPE TECH (BRISTOL) LTD·Filed 2016·Granted Oct 3, 2017·0 cites·6 claims
- 1849US2015306192A1Modified fviii apitope peptidesAPITOPE INT NV·Filed 2013·Application pending·0 cites
- 1948US10377800B2Myelin oligodendrocyte glycoprotein (MOG) peptideAPITOPE TECH BRISTOL LIMITED·Filed 2017·Granted Aug 13, 2019·0 cites·1 claims
- 2047US2010129853A1Disease markersAPITOPE TECHNOLOGY BRISTOL LTD·Filed 2008·Application pending·0 cites
- 2142US2015071967A1Tolerisation-Inducing CompositionUNIV BRISTOL·Filed 2013·Application pending·0 cites
- 2242US2018311328A1Peptide Selection MethodAPITOPE TECH BRISTOL LIMITED·Filed 2018·Application pending·0 cites
- 2341US8703705B2Modified factor VIII peptidesWRAITH DAVID·Filed 2010·Granted Apr 22, 2014·0 cites·10 claims
- 2439US2020046802A1Therapeutic method using tolerogenic peptidesAPITOPE INT NV·Filed 2018·Application pending·0 cites
- 2538US2019300573A1Human myosin peptidesAPITOPE INT NV·Filed 2017·Application pending·0 cites
- 2636US11542316B2S-Arrestin peptides and therapeutic uses thereofAPITOPE INT NV·Filed 2018·Granted Jan 3, 2023·0 cites·12 claims
- 2736US2003191063A1Peptide selection methodFiled 2001·Application pending·0 cites
- 2834US2022260587A1MethodWORG PHARMACEUTICALS HANGZHOU CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Wraith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →